[CME: Adrenal Insufficiency].

Area of Science:

• Endocrinology
• Internal Medicine

Background:

• Adrenal insufficiency (AI) symptoms are often nonspecific, leading to diagnostic delays.
• AI is a serious condition that can be life-threatening if not diagnosed promptly.
• Glucocorticoid medication is a common cause of central AI.

Purpose of the Study:

• To highlight the diagnostic challenges of adrenal insufficiency.
• To emphasize the importance of laboratory tests, particularly the ACTH-stimulation test.
• To outline management strategies for primary and central AI.

Main Methods:

• Review of diagnostic criteria for adrenal insufficiency.
• Discussion of the role of the ACTH-stimulation test.
• Analysis of treatment protocols for AI, including hydrocortisone and fludrocortisone.

Main Results:

• The ACTH-stimulation test is crucial for diagnosing AI.
• Glucocorticoid therapy is the most frequent cause of central AI.
• Hydrocortisone is the primary treatment, with dose adjustments critical for acute situations.

Conclusions:

• Prompt diagnosis of AI is essential due to its potential severity.
• Accurate diagnosis relies on specific laboratory tests like the ACTH-stimulation test.
• Treatment involves careful hydrocortisone management, with fludrocortisone reserved for primary AI.